Myocardial carnitine deficiency in acute myocardial infarction.

No abstract is available for this paper.

• Publication year

  1982

• Venue

  The Lancet

• Publication date

  1982-06-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(82)92540-5PMID 6123712
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cost-benefit analysis and immunization programmes in developing countries.

  1980cited by this paper
• Cost-benefit studies of vaccinations in Finland.

  1979cited by this paper
• Changes in tissue levels of carnitine and other metabolites during myocardial ischemia and anoxia.

  1978cited by this paper
• Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis.

  1977cited by this paper
• Automated method for L-carnitine determination.

  1976cited by this paper
• Acyl-CoA inhibition of adenine nucleotide translocation in ischemic myocardium.

  1975cited by this paper
• Concentration of carnitine in human muscle tissue.

  1974cited by this paper

• Improved Risk Prediction of Acute Myocardial Infarction in Patients With Stable Coronary Artery Disease Using an Amino Acid-Assisted Model

  2024cites this paper
• L‐carnitine alleviates cardiac microvascular dysfunction in diabetic cardiomyopathy by enhancing PINK1‐Parkin‐dependent mitophagy through the CPT1a‐PHB2‐PARL pathways

  2023cites this paper
• L-carnitine Extends the Telomere Length of the Cardiac Differentiated CD117+- Expressing Stem Cells.

  2020cites this paper
• Cardiac differentiation of bone-marrow-resident c-kit+ stem cells by L-carnitine increases through secretion of VEGF, IL6, IGF-1, and TGF-β as clinical agents in cardiac regeneration

  2020cites this paper
• Effect of Vitamins and Dietary Supplements on Cardiovascular Health

  2020cites this paper
• Association of Low Serum l-Carnitine Levels with Peripheral Arterial Stiffness in Patients Who Undergo Kidney Transplantation

  2019cites this paper
• Role of L-carnitine in protection against the cardiac oxidative stress induced by aspartame in Wistar albino rats

  2018cites this paper
• PROTECTIVE ROLE OF CARNITINE SYNERGIZED WITH VITAMIN E AGAINST ISOPROTERENOL INDUCED CARDIAC INFARCTION IN RATS

  2017cites this paper
• The role and place of cardioprotection with modern infusion solutions in the perioperative period

  2017cites this paper
• [Effect of L-Carnitine on QT Dispersion in Patients With Acute Coronary Syndrome].

  2015cites this paper
• Author ' s response to reviews Title : Effects of L-carnitine supplementation on oxidative stress and antioxidant enzymes activities in patients with coronary artery disease : a randomized , placebo-controlled trial

  2014cites this paper
• Effects of L-carnitine supplementation on oxidative stress and antioxidant enzymes activities in patients with coronary artery disease: a randomized, placebo-controlled trial

  2014cites this paper
• L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis.

  2013cites this paper
• L-carnitine--metabolic functions and meaning in humans life.

  2011cites this paper
• ROLE OF L-CARNITINE IN CONGESTIVE CARDIAC FAILURE

  2011cites this paper
• Biochemical Characterization of L-Carnitine Dehydrogenases from Rhizobium sp. and Xanthomonas translucens

  2010cites this paper
• Role of carnitine in cancer chemotherapy-induced multiple organ toxicity.

  2010cites this paper
• Nutritional treatments for acute myocardial infarction.

  2010cites this paper
• Implications cliniques de la carnitine au niveau du métabolisme énergétique et des maladies cardiovasculaires

  2008cites this paper
• Metabolic Treatment with L-Carnitine in Acute Anterior ST Segment Elevation Myocardial Infarction

  2006cites this paper
• The myocardial distribution and plasma concentration of carnitine in patients with mitral valve disease

  2006cites this paper
• Therapeutic Effects of l‐Carnitine and Propionyl‐l‐carnitine on Cardiovascular Diseases: A Review

  2004cites this paper
• L-Carnitine reduces malondialdehyde concentrations in isolated rat hearts in dependence on perfusion conditions

  2004cites this paper
• The role of carnitine in myocardial dysfunction.

  2003cites this paper
• Beneficial Effects of L-Carnitine in Dialysis Patients with Impaired Left Ventricular Function: An Observational Study

  2002cites this paper
• The use of ranolazine in cardiovascular disease

  2002cites this paper
• The Carnitine System Involvement in Mitochondrial Pharmacologic Sensitivity

  2002cites this paper
• USAGE OF CARNITINE IN BLOOD CARDIOPLEGIA IN CORONARY ARTERY BYPASS GRAFTING

  2002cites this paper
• Role of Metabolically Active Drugs in the Management of Ischemic Heart Disease

  2001cites this paper
• L‐Carnitine in Dialysis Patients

  2001cites this paper
• Influence of L-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass.

  2001cites this paper
• Myocardial infarction and left ventricular remodeling: results of the CEDIM trial. Carnitine Ecocardiografia Digitalizzata Infarto Miocardico.

  2000cites this paper
• Myocardial infarction and left ventricular remodeling: Results of the CEDIM trial

  2000cites this paper
• Decline of life’s energy theory of ageing 1. Revitalisation of energy metabolism and ageing mitochondria

  2000cites this paper
• Prolonged Oral L-carnitine Substitution Increases Bicycle Ergometer Performance in Patients with Severe, Ischemically Induced Cardiac Insufficiency

  1999cites this paper
• Effect of L-carnitine on myocardial metabolism: results of a balanced, placebo-controlled, double-blind study in patients undergoing open heart surgery.

  1998cites this paper
• Carnitine supplementation improves myocardial function in hearts from ischemic diabetic and euglycemic rats.

  1998cites this paper
• L-CARNITINE IN THE MANAGEMENT OF PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION : A COST EFFECTIVENESS ANALYSIS IN ITALY

  1998cites this paper
• Captopril in the management of patients after acute myocardial infarctions. A cost effectiveness analysis in Italy.

  1998cites this paper
• Carnitine Against Ischemia and Lipopolysaccharide Toxicity

  1997cites this paper
• Carnitine and its derivatives in cardiovascular disease.

  1997cites this paper
• Carnitines Increase Plasma Levels of Adenosine and ATP in Humans

  1997cites this paper
• Effect of L-Carnitine on the Limitation of Infarct Size in One-Month Postmyocardial Infarction Cases

  1996cites this paper
• A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction.

  1996cites this paper
• Anti-ischaemic efficacy of L-propionylcarnitine--a promising novel metabolic approach to ischaemia?

  1996cites this paper
• Myocardial carnitine deficiency in human cardiomyopathy

  1995cites this paper
• Additional antiischemic effects of long-term L-propionylcarnitine in anginal patients treated with conventional antianginal therapy

  1995cites this paper
• Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial.

  1995cites this paper
• Therapeutic potential of L-carnitine in patients with angina pectoris

  1995influential citation
• Effect of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a summary

  1995cites this paper
• Carnitine and myocardial infarction

  1995cites this paper
• Effects of L-propionylcarnitine on ischemia-induced myocardial dysfunction in men with angina pectoris.

  1994cites this paper
• Effect of propionyl-L-carnitine in a rat model of peripheral arteriopathy: A functional, histologic, and NMR spectroscopic study

  1993cites this paper
• L-carnitine in cardiogenic shock therapy: pharmacodynamic aspects and clinical data.

  1993cites this paper
• L‐Propionylcarnitine Does Not Affect Myocardial Metabolic or Functional Response to Chronotropic and Inotropic Stimulation After Repetitive Ischemia in Anesthetized Pigs

  1993cites this paper
• Metabolic management of ischaemic heart disease.

  1993cites this paper
• Functional and metabolic effects of propionyl-L-carnitine in the isolated perfused hypertrophied rat heart

  1992cites this paper
• Hemodynamic and Metabolic Activities of Propionyl‐L-Carnitine in Rats with Pressure‐Overload Cardiac Hypertrophy

  1992cites this paper
• Acute Improvement of Cardiac Function with Intravenous L‐Propionylcarnitine in Humans

  1992cites this paper
• The diabetic heart: metabolic causes for the development of a cardiomyopathy.

  1992cites this paper
• Myocardial Response to Reperfusion after a Prolonged Period of Ischaemia

  1992cites this paper
• Carnitine requirement of vascular endothelial and smooth muscle cells in imminent ischemia

  1992cites this paper
• Effect of L-carnitine on the cellular distribution of carnitine and its acyl derivatives in the ischemic heart.

  1992cites this paper
• The Effect of L‐Carnitine on Force Development of the Latissimus Dorsi Muscle in Dogs

  1991cites this paper
• Myocardial Response to Pretreatment with L-Carnitine in Patients with Cardiac Valve Replacement

  1991cites this paper
• Evaluation of the effect of intravenous L-carnitine therapy on function, structure and fatty acid metabolism of skeletal muscle in patients receiving chronic hemodialysis.

  1991cites this paper
• Muscle Carnitine Deficiency in Patients With Severe Peripheral Vascular Disease

  1991cites this paper
• Carnitine deficiency.

  1990cites this paper
• Carnitine: metabolism, function and clinical application.

  1990cites this paper
• Myocardial carnitine in end-stage congestive heart failure.

  1989cites this paper
• Rhythm of carnitine levels in serum and urine of normal subjects.

  1989cites this paper
• Direct chronotropic and inotropic effects of mildronate using cross-circulated dog atrial and ventricular preparations.

  1989cites this paper
• High doses of L-carnitine in acute myocardial infarction: metabolic and antiarrhythmic effects.

  1989cites this paper
• Bicycle ergometer and echocardiographic study in healthy subjects and patients with angina pectoris after administration of L-carnitine: semiautomatic computerized analysis of M-mode tracing.

  1988cites this paper
• Evaluation of the therapeutic efficacy of L-carnitine in congestive heart failure.

  1988cites this paper
• l-Carnitine

  1987cites this paper
• Carnitine metabolism and function in humans.

  1986cites this paper
• Effects of L-carnitine on exercise tolerance in chronic stable angina: a multicenter, double-blind, randomized, placebo controlled crossover study.

  1985cites this paper
• Crystal structures of carnitine and acetylcarnitine zwitterions: A structural hypothesis for mode of action

  1985cites this paper
• Effects of L-carnitine on exercise tolerance in patients with stable angina pectoris.

  1984cites this paper
• Correlation between increased serum and tissue L-carnitine levels and improved muscle symptoms in hemodialyzed patients.

  1983cites this paper
• Fatty Acid and Carnitine-Linked Abnormalities During Ischemia and Cardiomyopathy

  1983cites this paper
• Management of acute myocardial infarction with natural physiological agents.

  1983cites this paper
• Vascular Health and Risk Management Dovepress Critical Update for the Clinical Use of L-carnitine Analogs in Cardiometabolic Disorders

  year unknowncites this paper